Edition:
United Kingdom

CAS Medical Systems Inc (CASM.OQ)

CASM.OQ on NASDAQ Stock Exchange Capital Market

1.67USD
18 May 2018
Change (% chg)

$-0.02 (-1.18%)
Prev Close
$1.69
Open
$1.70
Day's High
$1.70
Day's Low
$1.57
Volume
94,851
Avg. Vol
12,029
52-wk High
$1.70
52-wk Low
$0.59

Latest Key Developments (Source: Significant Developments)

FDA Clears CASMED's Fore-Sight Tissue Oximetry OEM Module
Wednesday, 16 May 2018 

May 16 (Reuters) - CAS Medical Systems Inc ::FDA CLEARS CASMED’S FORE-SIGHT TISSUE OXIMETRY OEM MODULE.CAS MEDICAL SYSTEMS INC - EXPECTS A FILING WITH FDA FOR 510(K) CLEARANCE ON ITS FIRST OEM MODULE COMBINATION PRODUCT BEFORE END OF 2018.  Full Article

CAS Medical Systems Says Entered A Loan And Security Agreement With East West Bank Providing A 48-Month Term Loan Of $10 Mln
Tuesday, 8 May 2018 

May 8 (Reuters) - CAS Medical Systems Inc ::CAS MEDICAL SYSTEMS - ENTERED A LOAN AND SECURITY AGREEMENT WITH EAST WEST BANK PROVIDING A 48-MONTH TERM LOAN OF $10 MILLION - SEC FILING.CAS MEDICAL SYSTEMS - AGREEMENT ALSO PROVIDING A REVOLVING LOAN IN MAXIMUM OF $2 MILLION WHICH EXPIRES MAY 8, 2022.  Full Article

Cas Medical Systems Says Expects To Receive Regulatory Clearance For OEM Module In Q2 2018
Wednesday, 24 Jan 2018 

Jan 24 (Reuters) - Cas Medical Systems Inc ::CASMED SUBMITS FORE-SIGHT® OEM MODULE 510(K) TO FDA.CAS MEDICAL SYSTEMS INC - EXPECTS TO RECEIVE REGULATORY CLEARANCE FOR OEM MODULE IN Q2 OF 2018.CAS MEDICAL SYSTEMS INC - ANTICIPATES FILING FOR FDA CLEARANCE ON FIRST OEM MODULE COMBINATION PRODUCT BEFORE END OF 2018.  Full Article

CasMed Sees Q4 2017 Sales About $5.1 Million
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Cas Medical Systems Inc ::CASMED REPORTS PRELIMINARY NET SALES FOR THE 2017 FOURTH QUARTER.SEES Q4 2017 SALES ABOUT $5.1 MILLION.SEES FY 2017 SALES ABOUT $18.7 MILLION.- ‍EXPECTATIONS FOR 2018 INCLUDE LOW-TEENS PERCENTAGE INCREASE IN U.S. FORE-SIGHT SALES.  Full Article

‍Long Focus Capital Management Reports 6.9 Pct Passive Stake In CAS Medical Systems
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Cas Medical Systems Inc ::‍LONG FOCUS CAPITAL MANAGEMENT LLC REPORTS 6.9 PERCENT PASSIVE STAKE IN CAS MEDICAL SYSTEMS INC ​AS OF NOVEMBER 29 - SEC FILING.  Full Article

CASMED reports Q3 earnings per share $0.10
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Cas Medical Systems Inc :CASMED reports third-quarter 2017 financial results.Q3 earnings per share $0.10.Q3 sales $4.5 million versus $5.0 million.Cas Medical Systems Inc sees 2017 ‍total fore-sight oximetry sales to be flat to down slightly​.Cas Medical Systems Inc sees 2017 ‍total fore-sight sensor sales to increase in low single-digit percentages​.Cas Medical Systems Inc - ‍Company affirmed its financial guidance for 2017​.Cas Medical Systems Inc - "‍We are continuing on a path to cash flow breakeven, which we expect to reach in early 2019​".  Full Article

CASMED Q2 loss per share $0.08
Thursday, 4 Aug 2016 

Cas Medical Systems Inc : Q2 loss per share $0.08 . Q2 sales rose 18 percent to $5.5 million . Affirming expectation to ship a total of 400 fore-sight cerebral oximeters this year .Also on track to achieve our 2016 growth objective of fore-sight sales exceeding 20 percent.  Full Article

CAS Medical Systems says entered loan agreement with Solar Capital
Tuesday, 5 Jul 2016 

CAS Medical Systems Inc : Says entered into a loan and security agreement with Solar Capital Ltd - SEC filing . Says lenders are providing company with a 48-month secured term loan in the amount of $8 million . Says lenders are providing company with revolving loan in the maximum amount of $2.5 million .Says revolver expires on July 1, 2018 and the term loan matures on July 1, 2020.  Full Article

BRIEF-FDA Clears CASMED's Fore-Sight Tissue Oximetry OEM Module

* CAS MEDICAL SYSTEMS INC - EXPECTS A FILING WITH FDA FOR 510(K) CLEARANCE ON ITS FIRST OEM MODULE COMBINATION PRODUCT BEFORE END OF 2018 Source text for Eikon: Further company coverage: